Skip to Main Content

Paper Details

FOXA1 overexpression suppresses interferon signaling and immune response in cancer.
J Clin Invest
43
2021
Androgen, Androgen receptor, Androgen receptor-positive prostate cancer, BCa, FOXA1, IFN, IFN signaling gene, PCa, PCa and, STAT2, STAT2 DNA-binding domain, antigen presentation gene, bladder cancer, cancer, estrogen, estrogen receptor, estrogen receptor-positive luminal breast cancer, interferon, luminal PCa, melanoma, mice, patients, tumor
Author NameAffiliation
Yu-Tian XiaoShanghai Changhai Hospital
Vera J SumanMayo Clinic College of Medicine and Science
Richard M WeinshilboumMayo Clinic College of Medicine and Science
Liewei WangMayo Clinic College of Medicine and Science
Saravut J Weroha
Alan H BryceMayo Clinic College of Medicine and Science
Judy C Boughey
Charles M PerouLineberger Comprehensive Cancer Center, University of North Carolina
Matthew P Goetz
Matthew P GoetzMayo Clinic Cancer Center, Mayo Clinic College of Medicine and Science
Shancheng RenShanghai Changhai Hospital
  • 1 - 11

Datasets

Release 1.2